Skip to content
value.today

Recro Pharma

REPHUnlisted company
$75 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Recro Pharma timeline

1 events, 2014
  1. 2014
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Recro Pharma from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Recro Pharma

Acquisitions and changes
No longer listed: ticker REPH is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$124 M$248 M$373 M$497 M202020212022

World rank over time

▼ down 12,505 places since 2020
2020-01-01: #11437#11,43720202021-01-01: #19578#19,57820212022-01-07: #23942#23,9422022

Rank in USA: #2,545 (Jan 2020) · #3,896 (Jan 2021) · #4,629 (Jan 2022)

Lobbying by Recro Pharma#

$60 K spent on lobbying the US Congress and federal agencies in 2021, most often on health issues.

Lobbying, 2021
$60 K
#1,200 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2021
2026 so far
—
  • Health Issues1 report

Lobbying firms hired in 2021

BGR Government Affairs $60 K

Recro Pharma: lobbying spending by year
YearSpendingOwn lobbyistsReports
2021$60 K—1
2020$240 K—4
2019$240 K—4

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Recro Pharma, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at Recro Pharma#

5 labor condition applications certified in fiscal 2021 for 5 positions, at a median wage of $89 K a year.

Certified, FY2021
5
#1,191 among companies on value.today
Worker positions
5
Median wage offered
$89 K
a year, full-time
Applications filed
5
Recro Pharma: most frequent H-1B job titles in fiscal 2021
Job titlePositionsMedian wage offered
Scientist II, Analytical DevelopmentChemists3$90 K
Scientist II, Product DevelopmentMedical Scientists, Except Epidemiologists1$89 K
Scientist III, Analytical DevelopmentChemists1$87 K

Where: Gainesville, GA 5

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Recro Pharma, Inc.

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Recro Pharma🇺🇸$75 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 7, 2022 (last known)
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Recro Pharma? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Recro Pharma's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Recro Pharma? Suggest a correction